5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING MAJOR DEPRESSION Application EP-4349407-A2 European Patent Office 10 Apr 2024
Psilocybin and O-acetylpsilocin, salts and solid state forms thereof Grant US-11945832-B2 United States of America 02 Apr 2024
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11939346-B2 United States of America 26 Mar 2024
N,N-dimethyltryptamine and related psychedelics and uses thereof Grant US-11866408-B2 United States of America 09 Jan 2024
Psilocybin and O-acetylpsilocin, salts and solid state forms thereof Grant US-11851452-B2 United States of America 26 Dec 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11851451-B2 United States of America 26 Dec 2023
Methods and systems for the use of 3D human movement data Grant US-11806162-B2 United States of America 07 Nov 2023
Antidepressant-psilocybin co-treatment to assist psychotherapy Grant US-11801256-B2 United States of America 31 Oct 2023
Pharmaceutically acceptable salts and compositions thereof Grant US-11773063-B1 United States of America 03 Oct 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11738035-B2 United States of America 29 Aug 2023
Use of benzodiazepines to increase sensitivity to psilocybin following a chronic SSRI… Application GB-2615708-A United Kingdom 16 Aug 2023
Combination product for the treatment of neurological and/or psychiatric disorders Grant US-11723894-B2 United States of America 15 Aug 2023
PSILOCYBIN AND AN ADJUNCTIVE SEROTONIN REUPTAKE INHIBITOR FOR USE IN THE TREATMENT OF… Application WO-2023114097-A1 World Intellectual Property Organisation (WIPO) 22 Jun 2023
Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamine Grant US-11680044-B2 United States of America 20 Jun 2023
TREATMENT OF TREATMENT RESISTANT DEPRESSION WITH PSILOCYBIN Application WO-2023086252-A1 World Intellectual Property Organisation (WIPO) 19 May 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11629159-B2 United States of America 18 Apr 2023
Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine Grant US-11603353-B2 United States of America 14 Mar 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11564935-B2 United States of America 31 Jan 2023
ANTIDEPRESSANT-PSILOCYBIN CO-TREATMENT TO ASSIST PSYCHOTHERAPY Application WO-2022259046-A1 World Intellectual Property Organisation (WIPO) 15 Dec 2022
Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamine Grant US-11518742-B2 United States of America 06 Dec 2022
Pharmaceutical composition comprising 5-methoxy-N,N-dimethyltryptamine Grant US-11518743-B2 United States of America 06 Dec 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11505564-B2 United States of America 22 Nov 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11447510-B2 United States of America 20 Sep 2022
EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND OF LSD ANALOGS TO ASSIST PSYCHOTHERAPY… Application WO-2022175821-A1 World Intellectual Property Organisation (WIPO) 25 Aug 2022
TREATMENT OF SUICIDALITY WITH PSILOCIN OR PSILOCYBIN Application WO-2022150563-A1 World Intellectual Property Organisation (WIPO) 14 Jul 2022
USE OF BENZODIAZEPINES TO INCREASE SENSITIVITY TO PSILOCYBIN FOLLOWING A CHRONIC SSRI… Application WO-2022084480-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11180517-B2 United States of America 23 Nov 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11149044-B2 United States of America 19 Oct 2021
YEAST CELLS AND METHODS FOR PRODUCTION OF TRYPTOPHAN DERIVATIVES Application WO-2021052989-A1 World Intellectual Property Organisation (WIPO) 25 Mar 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10954259-B1 United States of America 23 Mar 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10947257-B2 United States of America 16 Mar 2021
TREATMENT OF DEPRESSION AND OTHER VARIOUS DISORDERS WITH PSILOCYBIN Application WO-2020212952-A1 World Intellectual Property Organisation (WIPO) 22 Oct 2020
COMPOSITIONS COMPRISING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR USE IN TREATING… Application WO-2020169851-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020
5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING DEPRESSION Application WO-2020169850-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020